Canaccord Adams Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Concerns Baked In
Tweet Send to a Friend
Canaccord Adams maintains a 'Buy' on Onyx Pharmaceuticals (Nasdaq: ONXX). Price target $45.
Canaccord analyst says, "See valuation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "See valuation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
